Journal article

Adverse events associated with intravenous immunoglobulin therapy

Hamrock D ...see all

Int.Immunopharmacol., vol. 6, issue 1567-5769 (Print) (2006) pp. 535-542

  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.
Sign in to save reference


In addition to its U.S. Food and Drug Administration (FDA) approved conditions, immune globulin intravenous (IGIV) is now being used to treat a vast array of autoimmune disorders. Some of the reasons for this overall increase in the use of IGIV include its effectiveness and safety. Despite many years of safe use, side effects and adverse reactions still occur. Common and mild side effects associated with IGIV include: headache, malaise, nausea, low-grade fever, urticaria, arthralgias, and myalgia. These symptoms typically resolve within a few days after their onset. Although rare, the serious and potentially fatal side effects include: anaphylactic reactions, aseptic meningitis, acute renal failure, stroke, myocardial infarction, and other thrombotic complications. Many of these side effects have occurred in patients who have significant, underlying risk factors for the development of the event. Thus, it is vitally important that a thorough and comprehensive medical evaluation be performed on every patient who is being evaluated for potential IGIV therapy. This evaluation can, to some extent, significantly minimize the risk of these side effects. Careful, constant, and close monitoring by trained personnel during the infusion can also result in early detection of such events. Physicians should thoroughly discuss the risks and benefits of IGIV with patients who are being considered for this therapy

Author-supplied keywords

  • Adverse Reactions
  • Arthralgia
  • Aseptic Meningitis
  • Autoimmune
  • Boston
  • DS - No ICSR
  • Disorders
  • England
  • Events
  • Failure
  • Fever
  • Food
  • Globulin
  • Headache
  • IGIV
  • Immune Globulin
  • Immunity
  • Infarction
  • Infusion
  • Intravenous Immunoglobulin Therapy
  • Ivig
  • Meningitis
  • Myocardial Infarction
  • Nausea
  • Onset
  • Patient
  • Risk
  • Risk Factors
  • Safety
  • United States
  • Urticaria
  • acute renal failure
  • article
  • complication
  • complications
  • detection
  • development
  • disorder
  • drug
  • drug administration
  • immune-globulin
  • immunoglobulin
  • immunoglobulin therapy
  • infection
  • intravenous
  • intravenous immunoglobulin
  • medicine
  • monitoring
  • myalgia
  • risk factor
  • side effect
  • side effects
  • therapy
  • use

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PMID: 16504916


  • D J Hamrock

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free